2026 article

2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Roger S. Blumenthal, Pamela B. Morris, Mario Gaudino, Heather M. Johnson, Timothy S. Anderson, Vera A. Bittner, Ron Blankstein, LaPrincess C. Brewer, Leslie Cho, Sarah D. de Ferranti, Eugenia Gianos, Ty J. Gluckman, Kristen Gradney, Ijeoma Isiadinso, Donald M Lloyd-Jones, Joel C. Marrs, Seth S. Martin, Kellie McLain, Laxmi S. Mehta, Samia Mora, Wudeneh Mulugeta, Pradeep Natarajan, Ann Marie Navar, Carl E. Orringer, Tamar S. Polonsky, Harmony R. Reynolds, Joseph J. Saseen, Michael D. Shapiro, Daniel E. Soffer, Sheila Tynes, Chloé Davidson Villavaso, Salim S. Virani, John T. Wilkins, ANAND ROHATGI SR., Samuel M. Kim, Karen P. Alexander, Cheryl Anderson, Catherine P. Benziger, Dave L. Dixon, Daniel Duprez, Keith C. Ferdinand, Anne C. Goldberg, Parag Joshi, Joshua W. Knowles, Carl (Chip) J. Lavie Jr, Jane A. Linderbaum, John W. McEvoy, Anurag Mehta, C. Noel Bairey Merz, Vijay Nambi, Ariela R. Orkaby, Jessica M. Peña, Robert Rosenson, Janelle Ruisinger, Sigrid Sandner, Stacey L. Schott, Laurence Sperling, Neil J. Stone, Peter Toth, Adam L. Ware, Seamus P. Whelton, James Young

81Citations signalées — pas une note de qualité

12Institutions déclarées

4Pays d’affiliation déclarés

Résumé fourni par la source

AIM: The "2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia" retires and replaces the "2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol." METHODS: A comprehensive literature search was conducted from October 2024 to December 2024 to identify clinical studies, systematic reviews and meta-analyses, and other evidence conducted on human participants that were published in English from MEDLINE (through PubMed), EMBASE, the Cochrane Library, Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. STRUCTURE: The focus of this clinical practice guideline is to address the evaluation, management, and monitoring of individuals with dyslipidemias, including high blood cholesterol, hypertriglyceridemia, and elevated lipoprotein(a).

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Date Crossref: 28/04/2026
Éditeur: Ovid Technologies (Wolters Kluwer Health)
Type: journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Joint Commission American Geriatrics Society American Occupational Therapy Association The Task Force for Global Health Association of Black Cardiologists American Pharmacists Association Foundation American College of Preventive Medicine House of Representatives American Society for Investigative Pathology Therapeutic Guidelines Chinese Preventive Medicine Association American Diabetes Association

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsNatural Products and Biological Research

Consulter la publication primaire DOI